Placental perfusion is the flow of blood through and around the placenta, the temporary organ that supplies a developing fetus with oxygen and nutrients throughout pregnancy. When that blood flow is healthy, the fetus grows on schedule and the pregnancy proceeds normally. When it falters, the consequences can range from restricted fetal growth to preeclampsia and, in severe cases, stillbirth. Understanding how placental perfusion works, what can disrupt it, and how clinicians monitor it sheds light on some of the most common and dangerous complications of pregnancy.
How Blood Actually Moves Through the Placenta
The placenta is unusual because it handles two separate blood supplies at once: the mother’s and the fetus’s. These two circulations come extraordinarily close to each other but never directly mix. Fetal blood flows through intricate networks of vessels confined within tree-like structures called villi, and those villous branches are bathed in pools of maternal blood.1PubMed Central. Blood flow and transport in the human placenta Oxygen and nutrients pass from the maternal blood across a thin tissue barrier into the fetal vessels, while carbon dioxide and waste move the other direction. The whole system depends on both circulations flowing at sufficient volume and pressure.
On the maternal side, blood reaches the placenta through specialized uterine vessels called spiral arteries. Early in pregnancy, cells from the developing placenta invade these arteries and physically remodel them, widening them and stripping away the muscular walls that would otherwise keep them constricted. The result is a set of large, low-resistance channels that can deliver the massive increase in blood flow a growing fetus demands.2PubMed Central. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction Mouse studies have confirmed that this remodeling process is critical: when it fails, maternal blood flow into the placenta drops, and fetal growth restriction or death can follow.3PubMed Central. VE-cadherin enables trophoblast endovascular invasion and spiral artery remodeling during placental development
On the fetal side, blood travels to the placenta through the umbilical arteries and returns oxygen-rich through the umbilical vein. The fetal vessels branch into progressively smaller capillaries within the villi, creating a huge surface area for gas exchange. Oxygen dissolved in the maternal blood diffuses across the villous membrane and into fetal plasma, where hemoglobin picks it up for transport back to the fetus.4PLOS ONE. Image-Based Modeling of Blood Flow and Oxygen Transfer in Feto-Placental Capillaries – Section: Results The efficiency of this exchange depends on how well both sides of the circulation are functioning.
The Chemical Balancing Act That Keeps Blood Flowing
Placental blood flow is not simply a matter of plumbing. The vessels on both sides are under active chemical control, and two molecules play starring roles: nitric oxide and endothelin-1. Nitric oxide is a vasodilator, meaning it relaxes blood vessel walls and encourages flow. Endothelin-1 is a vasoconstrictor that tightens them. In a healthy placenta, these two signals stay in balance, keeping the vessels open enough to deliver adequate blood without losing so much vascular tone that pressure drops dangerously.
Research on the fetal-placental circulation has shown that nitric oxide contributes to maintaining baseline vascular tone and actively counteracts the constricting effects of endothelin-1 and other vasoconstrictors.5American Journal of Obstetrics and Gynecology. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation The placenta itself produces endothelin-1, suggesting it plays a key role in fine-tuning local blood flow.6PubMed Central. Role of endothelin in uteroplacental circulation and fetal vascular function When the balance tips, either from too much constriction or too little relaxation, perfusion suffers. An imbalance between nitric oxide and endothelin-1 is one of the hallmarks of preeclampsia, where many of the condition’s symptoms can be traced back to disrupted vascular tone regulation.7PubMed. Nitric oxide/endothelin-1 in preeclampsia
The maternal cardiovascular system matters too. A study examining the relationship between maternal heart function and fetal blood flow found that mothers with high systemic vascular resistance and low cardiac output tended to have reduced umbilical vein flow and signs of increased resistance in the umbilical artery. This pattern was associated with fetal growth restriction.8American Journal of Obstetrics & Gynecology. The cardiac-fetal-placental unit In other words, the mother’s heart and blood vessels are not bystanders; they are active participants in how well the placenta gets perfused.
When Perfusion Goes Wrong
The single most important step in establishing good placental perfusion is the remodeling of the spiral arteries described above. When this remodeling fails or is incomplete, the arteries stay narrow and muscular, blood flow to the placenta is restricted, and a cascade of problems can follow. The placenta becomes under-perfused, the villous structures sustain damage, and the total capillary surface area shrinks, creating even more resistance to blood flow.9PubMed Central. Placental insufficiency and fetal growth restriction
Preeclampsia is probably the best-known condition linked to poor placental perfusion. When the placenta is ischemic (starved of blood), it releases substances into the mother’s bloodstream that cause widespread blood vessel dysfunction. One of the key culprits is a protein called sFlt-1, which mops up pro-growth signals like vascular endothelial growth factor and placental growth factor. The resulting imbalance contributes to the high blood pressure, protein in the urine, and organ damage that define preeclampsia.10PubMed Central. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension Current research is exploring the cellular mechanisms behind defective spiral artery remodeling in preeclampsia, including disrupted calcium handling in the smooth muscle cells of the spiral arteries and excess production of reactive oxygen species by mitochondria.11PubMed. Dysregulated Mitochondrial Calcium Causes Spiral Artery Remodeling Failure in Preeclampsia12PubMed Central. Mitochondrial ROS Accumulation Contributes to Maternal Hypertension and Impaired Remodeling of Spiral Artery but Not IUGR in a Rat PE Model Caused by Maternal Glucocorticoid Exposure The damage from defective remodeling also extends beyond the pregnancy itself, with links to long-term cardiovascular disease risk for the mother.13PubMed Central. Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease
Fetal growth restriction is the other major consequence. When the placenta cannot deliver enough oxygen and nutrients, the fetus simply does not grow at the expected rate. In severe cases, the fetus may redistribute its blood flow, prioritizing the brain and heart at the expense of other organs, a compensatory strategy that only works for so long before the situation becomes critical.
How Clinicians Assess Placental Perfusion
You cannot look at a pregnant person and tell how well their placenta is perfused, so clinicians rely on indirect and, increasingly, direct imaging tools. The most widely used is Doppler ultrasound, which measures the speed and pattern of blood flow in key vessels. Uterine artery Doppler performed around the second trimester can predict most cases of early-onset preeclampsia and intrauterine growth restriction, and it has become an essential part of first-trimester risk-prediction algorithms as preventive strategies have improved. Umbilical artery Doppler, meanwhile, helps identify which small-for-gestational-age fetuses are at genuine risk, as opposed to those that are simply constitutionally small.14PubMed. Doppler studies of placental function
A newer approach uses MRI with a technique called arterial spin labeling (ASL), which can measure perfusion directly without injecting contrast agents. This is particularly attractive for pregnancy because it avoids exposing the fetus to any contrast material. One study demonstrated that ASL MRI can noninvasively quantify total placental perfusion and detect differences in pregnancies affected by fetal heart disease.15JAMA Network Open. Arterial Spin Labeled MRI to Detect Early Placental Perfusion Differences in Fetal Heart Disease Another tracked placental perfusion over the course of pregnancy using ASL MRI in both healthy pregnancies and those complicated by chronic high blood pressure. In normal pregnancies, placental perfusion declined in the second trimester (a reflection of the expanding blood pool and changing placental architecture), while in pregnancies with chronic hypertension the pattern was different. Perfusion was significantly lower in women who went on to deliver small-for-gestational-age infants, suggesting this technique could serve as an early biomarker for placental insufficiency.16PubMed Central. Longitudinal assessment of placental perfusion in normal and hypertensive pregnancies using pseudo-continuous arterial spin-labeled MRI: preliminary experience
These MRI methods are still mostly in the research phase rather than routine clinical use, but they represent a significant step forward. Doppler ultrasound tells you about flow in specific arteries; ASL MRI tells you about perfusion of the placental tissue itself, which is closer to what actually matters for fetal oxygen delivery.
Practical Factors That Influence Perfusion
Some influences on placental perfusion are surprisingly mundane. Maternal position is one. An MRI study of healthy women in late pregnancy found that lying flat on the back (supine) caused roughly a 24% reduction in total blood flow to the uterus through the internal iliac arteries, along with a 6% reduction in oxygen transfer across the placenta.17PubMed Central. The effects of maternal position, in late gestation pregnancy, on placental blood flow and oxygenation: an MRI study This happens because the weight of the pregnant uterus compresses the large blood vessels that supply it when the mother lies on her back. In healthy pregnancies the fetus compensates reasonably well, but in pregnancies already affected by growth restriction, the effect is more worrying. A follow-up study found that growth-restricted fetuses, which are already chronically low on oxygen, experience a relatively larger decline in oxygen transfer when the mother lies supine compared to appropriately growing fetuses.18PubMed. The effect of maternal position on placental blood flow and fetoplacental oxygenation in late gestation fetal growth restriction: a magnetic resonance imaging study This is one of the reasons pregnant people are often advised to sleep on their side in the third trimester, particularly if there are concerns about fetal growth.
Low-dose aspirin is another practical intervention. Randomized trials and meta-analyses indicate that aspirin, started before 16 weeks of gestation at doses of 100 to 150 mg daily, can improve uteroplacental circulation and reduce the risk of both preeclampsia and fetal growth restriction.19International Journal of Community Pharmacy. Aspirin in the Prevention of Fetal Growth Restriction: Its Mechanisms and Clinical Outcomes The timing matters: aspirin works by modifying early placental development, so starting it later in pregnancy is much less effective. One trial that began aspirin at 23 weeks in women already showing abnormal uterine artery Doppler found no significant difference in preeclampsia rates compared to placebo.20PubMed. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation The takeaway is that interventions aimed at placental perfusion are most useful when they target the window during which the placenta is still being built.
Emerging Therapies Targeting the Placenta Directly
One of the frustrations in obstetric medicine is how few treatments exist once placental perfusion has already deteriorated. Delivering the baby early is often the only real option for severe cases, trading the risks of prematurity against the risks of remaining in a hostile uterine environment. Researchers are looking for ways to improve perfusion in situ, without ending the pregnancy.
An intriguing animal study tested a nanotechnology approach: liposomes loaded with tadalafil (a vasodilator best known by another brand name) were modified so they would anchor specifically to the placenta. In mice with induced growth restriction, these targeted liposomes continuously improved placental blood perfusion by boosting nitric oxide levels and restoring the balance between pro- and anti-angiogenic factors. Fetal weight increased and miscarriage rates fell, without detectable toxicity.21PubMed. Placenta-anchored tadalafil liposomes rescues intrauterine growth restriction through continuous placental blood perfusion improvement Targeting drugs to the placenta rather than flooding the mother’s whole body could, in theory, reduce side effects and improve efficacy, though this work is still in its early stages and far from clinical use.
In animal models of preeclampsia, targeting mitochondrial oxidative stress with specialized antioxidants has shown promise in improving spiral artery remodeling and uteroplacental blood flow while reducing maternal blood pressure.12PubMed Central. Mitochondrial ROS Accumulation Contributes to Maternal Hypertension and Impaired Remodeling of Spiral Artery but Not IUGR in a Rat PE Model Caused by Maternal Glucocorticoid Exposure These approaches highlight the gap between understanding the problem and having a fix: researchers can describe in granular detail what goes wrong at the cellular level, but turning that knowledge into safe, effective treatments for pregnant patients remains an enormous challenge.
Long-Term Consequences Beyond Pregnancy
Poor placental perfusion does not end its impact at delivery. For the baby, being born small because of inadequate placental blood flow carries health implications that can extend decades. Epidemiological and experimental studies have repeatedly shown that low birth weight is inversely associated with blood pressure and coronary heart disease later in life.22PubMed Central. Fetal programming and cardiovascular pathology The thinking is that a fetus deprived of adequate oxygen and nutrients adapts in ways that serve short-term survival but set the cardiovascular system up for problems down the road, a concept sometimes called fetal programming.
Mothers are affected too. A systematic review found that women who had pregnancies complicated by placenta-mediated diseases, including preeclampsia and fetal growth restriction, showed elevated markers of cardiovascular disease risk at various intervals after delivery.23PubMed. Placenta-mediated Pregnancy Complications and Their Association With Maternal Cardiovascular Disease Risk Factors Postpartum: A Systematic Review This is now recognized as a sex-specific risk factor for future cardiovascular problems, and increasingly, guidelines recommend postpartum cardiovascular screening for women who had these complications. A pregnancy complicated by poor placental perfusion, in other words, is not just a one-time event. It is a signal that both mother and child may need monitoring well into the future.
When the Placenta Starts Later Than We Thought
For most of the twentieth century, textbooks taught that maternal blood began flowing freely through the placenta from very early in the first trimester. That picture has been substantially revised. Studies of hysterectomy specimens from early pregnancy showed that plugs of trophoblast cells actually block the openings of the spiral arteries during the first weeks, preventing continuous maternal blood flow into the intervillous space. It is not until roughly 12 to 13 weeks that these plugs loosen and maternal blood flow becomes fully established.24PubMed. Maternal circulation in the first-trimester human placenta–myth or reality?
This delay appears to be protective. In the earliest weeks, the embryo is exquisitely vulnerable to oxidative damage. By keeping the intervillous space relatively low in oxygen, the trophoblast plugs create an environment where the embryo can develop without being exposed to the full force of the mother’s arterial oxygen levels. Once organogenesis is largely complete and the fetus can tolerate higher oxygen, the plugs dissolve and true perfusion begins. It is a remarkable bit of biological timing. The first microscopic images of the human placenta were obtained back in the 1830s, yet the organ’s fetal origin was not recognized until Hubrecht introduced the term “trophoblast” in 1889, and debates over how and when blood actually flows through it continued for another century.25PubMed. Shifting concepts of the fetal-maternal interface: a historical perspective
High Altitude and the Limits of Adaptation
One of the clearest natural experiments in placental perfusion occurs at high altitude, where the air contains less oxygen. Pregnancy at high elevation means the uteroplacental circulation has to work harder to deliver adequate oxygen to the fetus. In some populations that have lived at altitude for thousands of years, such as Andean and Tibetan groups, the uterine arteries have adapted, showing greater capacity to dilate during pregnancy than those of lowland women who move to altitude. But adaptation has limits. High-altitude hypoxia increases vascular tone in the uterine arteries and can blunt the normal pregnancy-related relaxation of those vessels, resulting in reduced blood flow.26Philosophical Transactions of the Royal Society B. The uteroplacental circulation at high altitude: adaptation and maladaptation
The consequences are measurable. Pregnancies at high altitude carry an increased risk of preeclampsia and decreased placental vascularization and perfusion.27PubMed Central. Placental Adaptation to Hypoxia: The Case of High-Altitude Pregnancies Birth weights tend to be lower. These effects make high-altitude populations valuable to researchers studying placental perfusion, because the environmental stress is clear and consistent, unlike the tangled web of factors that contribute to poor perfusion at sea level.
How Placental Design Varies Across Mammals
Humans are far from the only species whose reproduction hinges on placental perfusion, but not all placentas are alike. Mammalian placentas vary in shape, in how deeply the maternal and fetal tissues interdigitate, and in how many tissue layers separate the two blood supplies. Human placentas are disc-shaped (discoid) with a villous pattern of interdigitation, while rodents have a labyrinthine structure that provides even more surface area for exchange. Horses and pigs have diffuse placentas that cover much more of the uterine wall but are less intimately connected to the maternal circulation.28Evolution. Placental evolution from a three-dimensional and multiscale structural perspective – Section: The placenta of placental mammals
The ancestral placenta of all placental mammals was likely hemochorial (meaning maternal blood directly contacts fetal tissue), discoid, and labyrinthine, based on phylogenetic reconstructions.29PubMed Central. Evolution of the mammalian placenta revealed by phylogenetic analysis Humans retained the hemochorial interface and disc shape but shifted to a villous architecture. This variety matters because researchers studying placental perfusion in animal models need to account for the fact that a mouse placenta and a human placenta move blood very differently at the tissue level. It also means that findings from animal studies, while invaluable for understanding mechanisms, do not always translate straightforwardly to human pregnancies.
Studying the Placenta Outside the Body
One of the most important tools for understanding placental perfusion is, paradoxically, the placenta after it has been delivered. The ex vivo dual perfusion model takes a single lobe (called a cotyledon) from a freshly delivered human placenta and hooks it up to two separate artificial circulations, mimicking the maternal and fetal sides. Researchers can then pump fluid through it and study how various substances cross the barrier, how the vessels respond to drugs, and how the tissue metabolizes different compounds.30PubMed. Ex vivo dual perfusion of an isolated human placenta cotyledon: Towards protocol standardization and improved inter-centre comparability
This model has been used to study everything from how medications cross from mother to fetus to how nanoparticles and infectious organisms interact with the placental barrier.31Current Research in Toxicology. Placental transfer of tofacitinib in the ex vivo dual-side human placenta perfusion model It fills a critical gap: you obviously cannot experiment freely on a placenta inside a pregnant person, and animal placentas differ enough in structure that results do not always carry over. The limitation is that a perfused cotyledon sitting in a lab dish lacks the hormonal environment, immune interactions, and blood pressure dynamics of the living body. Still, for questions about barrier function and drug transfer, it remains one of the best tools available, and efforts to standardize the technique across laboratories are ongoing.